Distribution of endogenous tumour necrosis factor alpha in gliomas.
about
Angiogenic inhibition in high-grade gliomas: past, present and future.The Process and Regulatory Components of Inflammation in Brain Oncogenesis.Differential Characterization of Temozolomide-Resistant Human Glioma Cells.p38 MAPK inhibitors attenuate pro-inflammatory cytokine production and the invasiveness of human U251 glioblastoma cells.MiR-181b modulates EGFR-dependent VCAM-1 expression and monocyte adhesion in glioblastoma.
P2860
Distribution of endogenous tumour necrosis factor alpha in gliomas.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 1997
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Distribution of endogenous tumour necrosis factor alpha in gliomas.
@en
Distribution of endogenous tumour necrosis factor alpha in gliomas.
@nl
type
label
Distribution of endogenous tumour necrosis factor alpha in gliomas.
@en
Distribution of endogenous tumour necrosis factor alpha in gliomas.
@nl
prefLabel
Distribution of endogenous tumour necrosis factor alpha in gliomas.
@en
Distribution of endogenous tumour necrosis factor alpha in gliomas.
@nl
P2093
P2860
P356
P1476
Distribution of endogenous tumour necrosis factor alpha in gliomas.
@en
P2093
J S Kovach
T Yanagihara
P2860
P304
P356
10.1136/JCP.50.7.559
P407
P577
1997-07-01T00:00:00Z